Elon May Have a Huge Issue Because Microsoft Owns the “X” Trademark – Futurism
Elon May Have a Huge Issue Because Microsoft Owns the “X” Trademark Futurism
Archive for July, 2023
-
In: TRADEMARK NEWS
-
In: TRADEMARK NEWS
Duracell Can Register Three-Note Sound Trademark, Board Says – Bloomberg Law
Duracell Can Register Three-Note Sound Trademark, Board Says Bloomberg Law
-
In: TRADEMARK NEWS
MetaBirkin NFT Artist Appeals After Hermès Trademark Case Loss – Bloomberg Law
MetaBirkin NFT Artist Appeals After Hermès Trademark Case Loss Bloomberg Law
-
In: TRADEMARK NEWS
Twitter’s new ‘X’ logo to come with possible trademark issues – BNN Bloomberg
Twitter’s new ‘X’ logo to come with possible trademark issues BNN Bloomberg
-
In: PATENT NEWS
The Generative AI Revolution: Key Legal Considerations for the Consumer Products Industry
As discussed below, the US Court of Appeals for the Federal Circuit recently held in that according to the plain text of the Patent Act, AI cannot …
-
In: PATENT NEWS
Google owes $338.7 mln in Chromecast patent case, US jury says – Reuters.com
Google owes $338.7 mln in Chromecast patent case, US jury says Reuters.com Jury orders Google to pay $339M for patent-infringing Chromecast Ars Technica Google loses Chromecast patent dispute, must pay $338 million AppleInsider
-
In: TRADEMARK NEWS
Elon Musk Changes Twitter Name to X, But Microsoft Owns An X Trademark for All Computer Related Items That Could … – Showbiz411
Elon Musk Changes Twitter Name to X, But Microsoft Owns An X Trademark for All Computer Related Items That Could … Showbiz411
-
In: TRADEMARK NEWS
Meta appears to hold the rights to ‘X,’ could complicate Twitter rebrand – Business Insider
Meta appears to hold the rights to ‘X,’ could complicate Twitter rebrand Business Insider
-
In: PATENT NEWS
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied … – Financial Post
AbCellera’s ‘408 Patent is directed to microfluidic devices and using such … patent claims,” said Tryn Stimart, J.D., Chief Legal and Compliance …
-
In: PATENT NEWS
Exelixis, Teva reach settlement on Cabometyx patent dispute – Endpoints News
Associate Editor. Exelixis has settled a patent dispute over Teva’s attempt to market a generic version of its blockbuster cancer drug Cabometyx, …